No APOEε4 effect on coronary heart disease risk in a cohort with low smoking prevalence: the Whitehall II study
- 30 November 2004
- journal article
- review article
- Published by Elsevier BV in Atherosclerosis
- Vol. 177 (1), 105-112
- https://doi.org/10.1016/j.atherosclerosis.2004.06.008
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Synergistic Effect of Apolipoprotein E Polymorphisms and Cigarette Smoking on Risk of Ischemic Stroke in Young AdultsStroke, 2004
- Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E ε2/ε3/ε4 genotypeThe Lancet, 2003
- Cotinine levels and self-reported smoking status in patients attending a bronchoscopy clinicBiomarkers, 2003
- Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive menJournal Of Hypertension, 2002
- Influence of Apolipoprotein E, Smoking, and Alcohol Intake on Carotid AtherosclerosisStroke, 2002
- Impact of Alcohol Intake on Measures of Lipid Metabolism Depends on Context Defined by Gender, Body Mass Index, Cigarette Smoking, andApolipoprotein EGenotypeArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Association of APOE ε2/ε3/ε4 and promoter gene variants with dementia but not cardiovascular mortality in old ageAmerican Journal of Medical Genetics, 2002
- Impact of age and body size on inter‐individual variation in measures of lipid metabolism: influence of gender and apolipoprotein E genotypeClinical Genetics, 2000
- Apolipoprotein E polymorphism and Alzheimer's diseaseThe Lancet, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993